Management Team

Robert C. McInnis, President & Chief Executive Officer
Bob joined PharmaGap in December 2004. Prior to this, Bob was the Director of Financial Programs at World Heart Corporation, dealing with various financial structuring programs including responsibility for U.S. and Canadian capital markets regulatory affairs. Previously, Bob was president of SC Stormont Corporation and was involved in the corporate financial management for the Ottawa Senators Hockey Club and The Corel Centre. Before that, Bob was employed at SHL Systemhouse Inc., at the time, Canada’s largest computer system integration company where he held a number of key financial management roles including corporate structuring, and mergers and acquisitions activity. Bob is a chartered accountant and holds a Bachelor of Mathematics degree from the University of Waterloo.

Kenneth K. Sokoll, V.P. Clinical Development, C.O.O.
Dr. Kenneth K. Sokoll, Ph.D. has been Chief Operating Officer and Vice President of Clinical Development at Pharmagap Inc. since September 2010. Dr. Sokoll is responsible for the clinical development of Pharmagaps lead drug candidates, preclinical development, and chemistry, manufacturing and control (CMC) requirements, among others. He has served in an executive role in the drug development industry since 2003, and has experience in a variety of product development roles since 1994 in Canada, the U.S., and France. He has extensive hands-on experience in the planning, management, oversight, and delivery of clinical programs and has served as the Vice President of Drug Development at both Milestone Pharmaceuticals Inc. and Liponex Inc. (2005- 2009). Prior to joining Liponex Inc., Dr. Sokoll spent four years (2001-2005) at United Biomedical Inc. in the U.S. where he began as manager of the formulations group ultimately holding the position of Vice President of Vaccine Product Development, where he served as the Responsible Head for Regulatory Affairs. His work has been published in multiple peer-reviewed publications and he holds a number of patents in the drug and vaccine delivery area. Throughout his career Dr. Sokoll has gained a wealth of experience in the life sciences sector, holding positions as a research scientist and management positions from 1994-2001 with companies such as PMC-Canada and Rhodia/Aventis Pasteur-France. In addition, Dr. Sokoll has received prestigious awards, scholarships and has been the principal investigator (P.I.) or co-P.I. on several grants for his work in life sciences, including the Marie Curie Fellowship grant and an NIH development contract for the development of an HIV vaccine. Dr. Sokoll has a B.Sc. from the University of Toronto and a Ph.D. in Organic Chemistry from the University of Waterloo.

Jenny Phipps, Ph.D., Chief Scientific Officer, Director
Co-founder of PharmaGap. Jenny is an experienced molecular biologist with a strong interest in signal transduction processes and their effect on disease. As CSO, Jenny designed and implemented the core drug development program targeting PKC. Before joining the Company full-time in 2001, Jenny was a senior researcher at the National Research Council of Canada in Ottawa, an adjunct professor at the University of Ottawa (School of Medicine) and an assistant professor of biology at Carleton University (Ottawa). She has a Doctorate (Molecular Genetics) from the Universite Paul Sabatier (France).

Gerald Leahy, Chief Financial Officer
Gerald joined Pharmagap as Chief Financial Officer in December, 2004 bringing more than 20 years of industry experience in public and private companies, including 14 years in the high-tech sector. As a financial professional he has successfully developed and managed finance groups throughout the building and growth stages of companies. He has been involved in private and public financings, international expansion into foreign markets as well as reorganizations. Gerald was a key player in Simware Inc.’s Nasdaq IPO and the eventual merger with Netmanage Inc., and also recently acted as CFO during Linmor Inc.’s strategic sale to Nuvo Network Management Inc. Gerald is a CMA and holds a Bachelor of Commerce degree from Carleton University.